文献速递免疫规划慢病防控与筛查卫生政策与健康促进

美国老年人带状疱疹疫苗接种率在COVID-19大流行前后的变化

Change in herpes zoster vaccination uptake before and during the COVID-19 pandemic in the United States older adults.
PubMed 文献 · Vaccine · 2025-07-12

研究基于美国全国健康访谈调查数据,纳入79,786名≥50岁成人,比较2018-2019年与2020-2022年带状疱疹疫苗接种率变化。接种率从大流行前的25.1%升至大流行期间的30.1%,调整后患病率比为1.36(95%CI 1.30-1.41),各亚组均有上升,但部分弱势亚组接种率仍显著低于其他人群,总体接种率仍不理想。

要点

  • ≥50岁成人带状疱疹疫苗接种率从大流行前的25.1%升至大流行期间的30.1%,调整后患病率比1.36(95%CI 1.30-1.41)。
  • 接种率上升在所有亚组中均可见,在50-64岁、男性、非西班牙裔黑人及其他族裔、低收入、西部、与伴侣同住、当前吸烟、既往接种流感疫苗及无合并症者中更明显。
  • 尽管上升,大流行期间上述亚组的接种率仍显著低于其他人群,总体接种率仍不理想。

核心结论

  • 美国≥50岁成人带状疱疹疫苗接种率在大流行期间较之前上升,且在少数族裔、低收入、肥胖和吸烟人群中上升更明显,但接种率仍不理想。
  • 随着人口老龄化,需要持续监测和更好的策略以确保接种率继续上升。

研究设计与样本

  • 利用美国全国健康访谈调查数据,估计2018-2019年(大流行前)和2020-2022年(大流行期间)≥50岁成人的带状疱疹疫苗接种率。
  • 采用对数二项回归,调整社会人口学和健康特征并按这些特征分层,分析接种率变化。
  • 共纳入79,786名成人,平均年龄66.4岁,男性占55.6%。

主要发现

  • 带状疱疹疫苗接种率从大流行前的25.1%升至大流行期间的30.1%,调整后患病率比为1.36(95%CI 1.30-1.41)。
  • 接种率上升在所有亚组中均观察到,在50-64岁、男性、非西班牙裔黑人及其他族裔、低收入、西部、与伴侣同住、当前吸烟、既往接种流感疫苗及无合并症者中更明显。
  • 尽管上升,大流行期间上述亚组的接种率仍显著低于其他人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine changes in herpes zoster (HZ) vaccination uptake among older adults in the United States before and during the COVID-19 pandemic and related factors. METHODS: We estimated HZ vaccination uptake before (2018-2019) and during (2020-2022) the COVID-19 pandemic among adults aged ≥50 years using the National Health Interview Survey data. We used log-binomial regression to examine uptake changes with adjustment for and stratification by sociodemographic and health characteristics. RESULTS: Among 79,786 adults (mean age: 66.4 years; male: 55.6 %), the uptake prevalence increased from 25.1 % before the pandemic to 30.1 % during the pandemic, with a 1.36-fold increase in prevalence (adjusted prevalence ratio: 1.36 [95 % CI: 1.30-1.41]). Such increase was observed across all subgroups, with more prominent increases among adults aged 50-64 years, men, non-Hispanic Black and other ethnicity, those with low household income, from West regions, living with partners, current smokers, received prior flu vaccinations, and those without comorbidities. Despite these increases, the uptake during the pandemic remained significantly lower in these subgroups compared to others. CONCLUSIONS: Although HZ vaccination uptake among older adults increased during the COVID-19 pandemic compared to before the pandemic, and this increase was more prominent among ethnic minorities, low-income, and obese and smoker groups, uptake remains suboptimal. With the ageing population, ongoing monitoring and better strategies are required to ensure uptake continues to increase.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lin J, Dai Z, Li C, et al. Change in herpes zoster vaccination uptake before and during the COVID-19 pandemic in the United States older adults. Vaccine. 2025. PMID: 40652679. doi:10.1016/j.vaccine.2025.127503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。